[
1.. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 4(2):295–306.10.1111/j.1538-7836.2006.01753.x16420554
]Search in Google Scholar
[
2. Tektonidou MG. Renal involvement in the antiphospholipid syndrome (APS)-APS nephropathy. Clin Rev Allergy Immunol (2009) 36(2–3):131–40.10.1007/s12016-008-8112-z19048414
]Search in Google Scholar
[
3. Abu-Shakra M, Urowitz MB, Gladman DD, Ritchie S. The significance of anticardiolipin antibodies in patients with lupus nephritis. Lupus (1996) 5(1):70–3.10.1177/0961203396005001138646230
]Search in Google Scholar
[
4. Bhandari S, Harnden P, Brownjohn AM, Turney JH. Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. QJM (1998) 91(6):401–9.10.1093/qjmed/91.6.4019709458
]Search in Google Scholar
[
5. Moroni G, Ventura D, Riva P, Panzeri P, Quaglini S, Banfi G, et al. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am J Kidney Dis (2004) 43(1):28–36.10.1053/j.ajkd.2003.09.01114712424
]Search in Google Scholar
[
6. Natejumnong C, Ruangkanchanasetr P, Aimpun P, Supaporn T. Significance of antiphospholipid antibodies in lupus nephritis. J Med Assoc Thai (2006) 89(Suppl 2): S121–8.
]Search in Google Scholar
[
7. Frampton G, Hicks J, Cameron JS. Significance of anti-phospholipid antibodies in patients with lupus nephritis. Kidney Int (1991) 39(6):1225–31.10.1038/ki.1991.1551716712
]Search in Google Scholar
[
8. Parodis I, Arnaud L, Gerhardsson J, Zickert A, Sundelin B, Malmström V, et al. Antiphospholipid antibodies in lupus nephritis. PLoS One (2016) 11(6): e0158076.10.1371/journal.pone.0158076491900727336701
]Search in Google Scholar
[
9. Mehrani T, Petri M. IgM anti-beta2 glycoprotein I is protective against lupus nephritis and renal damage in systemic lupus erythematosus. J Rheumatol (2011) 38(3):450–3.10.3899/jrheum.10065021123325
]Search in Google Scholar
[
10. Appel GB, Pirani CL, D’Agati V. Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol (1994) 4(8):1499–515.10.1681/ASN.V4814998025223
]Search in Google Scholar
[
11. Farrugia E, Torres VE, Gastineau D, Michet CJ, Holley KE. Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study. Am J Kidney Dis (1992) 20(5):463–7110.1016/S0272-6386(12)70258-51442758
]Search in Google Scholar
[
12. Hughson MD, Nadasdy T, McCarty GA, Sholer C, Min KW, Silva F. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Kidney Dis (1992) 20(2):150–8.10.1016/S0272-6386(12)80543-9
]Search in Google Scholar
[
13. Bridoux F, Vrtovsnik F, Noël C, Saunier P, Mougenot B, Lemaitre V, et al. Renal thrombotic microangiopathy in systemic lupus erythematosus: clinical correlations and long-term renal survival. Nephrol Dial Transplant (1998) 13(2):298–304.10.1093/oxfordjournals.ndt.a0278229509438
]Search in Google Scholar
[
14. Zheng H, Chen Y, Ao W, Shen Y, Chen XW, Dai M, et al. Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases. Arthritis Res Ther (2009) 11(3): R93.10.1186/ar2736271414919545416
]Search in Google Scholar
[
15. Song D, Wu LH, Wang FM, Yang XW, Zhu D, Chen M, et al. The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther (2013) 15(1): R12.10.1186/ar4142367279223320601
]Search in Google Scholar
[
16. Wu LH, Yu F, Tan Y, Qu Z, Chen MH, Wang SX, et al. Inclusion of renal vascular lesions in the 2003 ISN/RPS system for classifying lupus nephritis improves renal outcome predictions. Kidney Int (2013) 83(4):715–23.10.1038/ki.2012.40923302713
]Search in Google Scholar
[
17. Tektonidou MG, Sotsiou F, Moutsopoulos HM. Antiphospholipid syndrome nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS. J Rheumatol (2008) 35:1983–8.
]Search in Google Scholar
[
18. Rekvig OP, Nossent JC. Anti-double-stranded DNA antibodies, nucleosomes, and systemic lupus erythematosus: a time for new paradigms? Arthritis Rheum. 2003 Feb;48(2):300–312.10.1002/art.1073912571837
]Search in Google Scholar
[
19. Hernando Monserrat, González Concepción, Sánchez Angel, Guevara Paloma, Navajo José Alejandro, Papisch Wolfgang, González-Buitrago José Manuel. Clinical evaluation of a new automated anti-dsDNA fluorescent immunoassay. Clin Chem Lab Med. 2002 Oct;40(10):1056–1060.10.1515/CCLM.2002.18512476949
]Search in Google Scholar
[
20. 20.Cervera R, Espinosa G. Update on the catastrophic antiphospholipid syndrome and the “CAPS Registry”. Semin Thromb Hemost. 2012 Jun;38(4):333-8.10.1055/s-0032-130471822618528
]Search in Google Scholar
[
21. Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J: Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 59: 2156–2163, 200110.1046/j.1523-1755.2001.00730.x11380817
]Search in Google Scholar
